Anne-Marie Fields
Managing Director, Precision AQ
Replay available
Cellectar Biosciences, Inc. (NASDAQ: CLRB) Q1 2026 earnings conference call, held 2026-05-14. Replay captured from the company's public earnings webcast.

Managing Director, Precision AQ
Chief Operating Officer, Selectar Biosciences
President and CEO, Selectar Biosciences
Analyst, Lannenberg Thalmann
Chief Financial Officer, Selectar Biosciences
Watch the replay and follow the connected company analysis, news, and investor updates for Cellectar Biosciences, Inc..
WEBVTT 00:00:22.171 -- 00:00:24.171 Thank 00:00:27.967 -- 00:00:29.967 you. 00:01:58.662 -- 00:02:00.305 Thank 00:02:00.305 -- 00:02:03.046 you. Thank 00:02:07.237 -- 00:02:09.237 you. 00:02:23.435 -- 00:02:25.435 Thank 00:02:32.206 -- 00:02:34.206 you. 00:02:54.468 -- 00:02:56.468 Thank 00:03:01.747 -- 00:03:03.747 you. 00:04:10.878 -- 00:04:12.878 Thank 00:04:29.465 -- 00:04:31.465 you. 00:04:59.427 -- 00:05:01.427 Thank 00:05:13.365 -- 00:05:15.365 you. 00:06:57.603 -- 00:06:59.603 Thank 00:07:02.311 -- 00:07:04.311 you. 00:07:24.839 -- 00:07:26.839 Ladies 00:07:51.145 -- 00:07:54.151 and gentlemen, thank you for standing by and welcome. 00:07:54.151 -- 00:07:57.595 At this time, all participants are in a listen-only mode. 00:07:57.595 -- 00:08:01.199 Following the presentation, there will be a question-and-answer session. 00:08:01.199 -- 00:08:04.564 Please be advised that today's conference call may be recorded. 00:08:04.564 -- 00:08:09.469 I would now like to hand the conference call over to Anne-Marie Fields, Managing Director 00:08:09.469 -- 00:08:13.234 at Precision AQ. Please go ahead. 00:08:13.234 -- 00:08:17.539 Thank you, Vanessa. Good morning, and welcome to Selectar Biosciences' first quarter 00:08:17.539 -- 00:08:21.504 2026 Financial Results and Business Update conference call. 00:08:21.504 -- 00:08:26.122 Joining us today from Selectar are Jim Caruso, President and CEO, who will provide an 00:08:26.122 -- 00:08:30.966 overview of the company's progress before turning the call over to Chad Colleen, CFO, 00:08:30.966 -- 00:08:36.051 for a financial review of the quarter. Following this, Jared Lancourt, Chief Operating 00:08:36.051 -- 00:08:39.835 Officer, will give an update on the company's progress and plans for its promising clinical 00:08:39.835 -...